GlassScriptPhysician profile
David Louis Colen
NPI 1245677970
$6,621.59
in general payments reported to CMS, 2019-2025
13 companies · $1,756 in 2025
The $1,756 reported for 2025 was more than what 83% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,550 · 2021: $173 · 2022: $602 · 2023: $426 · 2024: $115 · 2025: $1,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,736 · Travel and Lodging: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,736.29 |
| Travel and Lodging | $560.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,826.12 | 2019-2022 | |
| Sonex Health, INC. | $1,658.42 | 2023-2025 | Sx-One Microknife |
| Medical Device Business Services, INC. | $1,617.86 | 2019 | |
| Axogen | $350.41 | 2023 | Avance Nerve Graft |
| Polaris Technology Solutions LLC | $343.95 | 2022 | |
| Sientra, INC. | $277.88 | 2019 | |
| Orthofix Medical, INC. | $172.94 | 2025 | Fitbone |
| Skeletal Dynamics INC | $144.00 | 2021 | |
| Integra Lifesciences Corporation | $118.77 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $43.85 | 2019 | |
| Zimmer Biomet Holdings, INC. | $42.13 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $25.26 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Colen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.